EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Potential of photon-counting detector CT technology for contrast medium reduction in portal venous phase thoracoabdominal CT

Daniel Popp, Martin Siedlecki, Lena Friedrich, Mark Haerting, Christian Scheurig-Muenkler, Florian Schwarz, Thomas Kroencke, Stefanie Bette, Josua A Decker

European Radiology · 2025

DOI: 10.1007/s00330-025-11409-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Radiology, 2025. Verfasst von Daniel Popp und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic and Interventional Radiology, University Hospital Augsburg, Faculty of Medicine, University of Augsburg, Augsburg, Germany. Hauptthemen laut MEDLINE: Contrast Media, Tomography, X-Ray Computed, Portal Vein, Radiography, Abdominal. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To compare image quality and iodine attenuation intra-individually in portal venous phase photon-counting detector CT (PCD-CT) scans using protocols with different contrast medium (CM) volume. Materials and methods A prospectively acquired patient cohort between 04/2021 and 11/2023 was retrospectively screened if patients had the following combination of portal venous phase thoracoabdominal CT scans: (a) PCD-CT with 120 mL CM volume (PCD-CT 120 mL ), (b) PCD-CT with 100 mL CM volume (PCD-CT 100 mL ), and (c) prior energy-integrating detector CT (EID-CT) with 120 mL CM volume. On PCD-CT, virtual monoenergetic image (VMI) reconstructions at 70 keV were applied for both groups as well as additional VMI at 60 keV for PCD‑CT 100 mL . Quantitative analyses including signal-to-noise (SNR) and contrast-to-noise ratios (CNR) and qualitative analyses were performed using a mixed linear effects model.

Results

The final study cohort comprised 49 patients (mean age 67 [31–86] years, 12 female). Comparison to EID-CT was available in 33 patients. In standard 70 keV VMI reconstructions, PCD-CT 100 mL was non-inferior to PCD-CT 120 mL as well as to EID-CT 120 mL for CNR in abdominal organs (all p > 0.050). The mixed linear effects model revealed significant differences between contrast volume groups for both contrast enhancement and image quality ratings. PCD-CT 100 mL/70 keV demonstrated the smallest deviation from optimal contrast enhancement (−0.306, p < 0.001).

Conclusion

In portal venous phase thoracoabdominal PCD-CT, a nearly 17% reduction in CM was achievable while maintaining subjective and objective image quality compared to prior higher CM volume PCD-CT scans within the same patients and still surpassing image quality of previous exams on an EID-CT system. Key Points Question How do image quality and iodine attenuation intra-individually compare in portal venous phase photon-counting detector CT (PCD-CT) scans using protocols with different contrast medium volume.

Findings

PCD-CT scans exhibit superior quantitative and qualitative image quality compared to energy-integrating detector-CT acquisitions and are not negatively affected by contrast volume reductions up to 17%. Clinical relevance This study provides further evidence that PCD-CT enables a considerable reduction in iodine dose for portal venous phase acquisition, benefiting both patients and healthcare system costs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Contrast MediaTomography, X-Ray ComputedPortal VeinRadiography, AbdominalRadiography, ThoracicHumansFemaleMaleMiddle AgedAgedRetrospective StudiesAged, 80 and overAdultSignal-To-Noise RatioPhotonsRadiographic Image Interpretation, Computer-Assisted

Stichwörter der Autor:innen

Contrast mediumIodine contrastOncologic imagingPhoton-counting detector computed tomographyVirtual monoenergetic imaging

Substanzen

Contrast Media

Autor:innen und Institutionen

  • Department of Diagnostic and Interventional Radiology, University Hospital Augsburg, Faculty of Medicine, University of Augsburg, Augsburg, Germany.
  • Department of Radiology and Nuclear medicine, Kantonspital St. Gallen, St. Gallen, Switzerland.
  • Institute for Radiology, DONAUISAR Hospital Deggendorf-Dingolfing-Landau, Deggendorf, Germany.
  • Medical Faculty, Ludwig Maximilian University Munich, Munich, Germany.
  • Department of Diagnostic and Interventional Radiology, University Hospital Augsburg, Faculty of Medicine, University of Augsburg, Augsburg, Germany. Thomas.Kroencke@uk-augsburg.de.
  • Centre for Advanced Analytics and Predictive Sciences (CAAPS), University of Augsburg, Augsburg, Germany. Thomas.Kroencke@uk-augsburg.de.

Zitieren

APA

Popp, D., Siedlecki, M., Friedrich, L., Haerting, M., Scheurig-Muenkler, C., Schwarz, F., Kroencke, T., Bette, S., & Decker, J. A. (2025). Potential of photon-counting detector CT technology for contrast medium reduction in portal venous phase thoracoabdominal CT. European Radiology. https://doi.org/10.1007/s00330-025-11409-3

Vancouver

Popp D, Siedlecki M, Friedrich L, Haerting M, Scheurig-Muenkler C, Schwarz F, et al. Potential of photon-counting detector CT technology for contrast medium reduction in portal venous phase thoracoabdominal CT. European Radiology. 2025. doi:10.1007/s00330-025-11409-3

BibTeX
@article{Popp2025,
  author = {Popp, Daniel and Siedlecki, Martin and Friedrich, Lena and Haerting, Mark and Scheurig-Muenkler, Christian and Schwarz, Florian and Kroencke, Thomas and Bette, Stefanie and Decker, Josua A},
  title = {Potential of photon-counting detector CT technology for contrast medium reduction in portal venous phase thoracoabdominal CT},
  journal = {European Radiology},
  year = {2025},
  doi = {10.1007/s00330-025-11409-3}
}
Kostenlos starten →